The pill debossed with the imprint K 18 is a generic formulation of Oxycodone Hydrochloride (5 mg). Manufactured by KVK-Tech, Inc., this medication is a powerful opioid analgesic (pain reliever). It is prescribed to manage acute pain severe enough to require an opioid treatment when alternative, non-opioid options are inadequate. Because of its high potential for abuse, addiction, and physical dependence, it is classified as a Schedule II Controlled Substance in the United States.
Pill Identification
Because immediate-release opioids are a frequent target for illicit counterfeiting, careful physical identification of this medication is vital.
- Imprint: “K 18” is debossed on the face of the tablet. Typically, the “K” is on one side of a score line and “18” is on the other.
- Color: Solid white.
- Shape: Round, flat-faced, with beveled edges.
- Size: Very small, measuring approximately 6.00 mm in diameter.
- Structure: It contains a single score line across the middle, allowing it to be broken cleanly into two 2.5 mg segments if a halved dose is clinically directed.
- Composition: It contains pure oxycodone hydrochloride (5 mg) and does not include secondary analgesics like acetaminophen (Tylenol), distinguishing it from combination drugs like Percocet.
- Counterfeit Counter-Measure: Counterfeit pills printed with the “K 18” mark are widespread on the illicit market. Street-sourced versions are frequently pressed using deadly amounts of fentanyl. Authentic pills from a licensed pharmacy exhibit precise machine-stamping, uniform thickness, and do not crumble easily upon light handling.
Mechanism of Action
Oxycodone is a semi-synthetic opioid agonist derived from the poppy alkaloid thebaine. It primarily acts on the central nervous system (CNS) to alter both the perception of pain and the emotional response to it.
Once ingested, oxycodone selectively binds to stereospecific opioid receptors (mu-opioid receptors) located in the brain, spinal cord, and smooth muscle tissues. As an agonist, it stimulates these receptors, initiating a cascade of intracellular events:
- It inhibits the enzyme adenylyl cyclase, reducing intracellular cyclic adenosine monophosphate (cAMP).
- It closes voltage-gated calcium channels and opens inwardly rectifying potassium channels.
This action hyperpolarizes the post-synaptic neurons, severely inhibiting the transmission of nociceptive (pain) signals up the spinal cord to the brain. Additionally, by activating opioid receptors in the brain’s reward centers, it causes a surge of dopamine, which produces feelings of sedation, relaxation, and euphoria.
Indications & Dosage
The K 18 pill is an immediate-release (IR) formulation. It dissolves rapidly in the gastrointestinal tract, with pain relief beginning within 20 to 30 minutes, peaking in the bloodstream at around 1 hour, and lasting between 4 and 6 hours.
Approved Clinical Uses
- Management of acute, severe pain (e.g., post-operative recovery, severe trauma, or acute orthopedic injuries).
- Breakthrough pain management in cancer or palliative care patients already established on baseline long-acting opioids.
Standard Adult Dosage Framework
Dosing must be strictly tailored by a physician based on the patient’s pain severity, previous opioid exposure, and individual metabolic risk factors.
- Naïve Opioid Users (Initial Dose): The typical starting dose is 5 mg (one full tablet) taken orally every 4 to 6 hours as needed for acute pain.
- Adjustments: In some cases involving highly sensitive individuals or elderly patients, a clinician may instruct starting with 2.5 mg (half a tablet).
- Duration: Therapy should be limited to the shortest duration necessary, often spanning just a few days following an acute injury or surgery.
Side Effects
Oxycodone affects multiple organ systems, resulting in predictable physiological side effects. These can range from common mild symptoms to rare, acute medical emergencies.
Common Side Effects
These arise from the drug’s depressive effect on the CNS and gastrointestinal smooth muscle:
- Gastrointestinal: Constipation (due to decreased intestinal motility), nausea, vomiting, and dry mouth.
- Neurological: Drowsiness, profound lethargy, dizziness, headache, and lightheadedness.
- Dermatological: Pruritus (intense itching) and flushing caused by opioid-induced histamine release.
Severe Side Effects
Immediate medical intervention is required if any of the following present:
- Respiratory Problems: Unusually slow, shallow, or labored breathing.
- Severe Hypotension: An intense drop in blood pressure, leading to fainting (syncope) or profound circulatory collapse.
- Neurological Emergencies: Severe confusion, hallucinations, or a state of stupor.